These findings support the hypothesis that the GnRH test may be more effective in eliciting a robust gonadotropin response in younger patients, and that the diagnostic performance of triptorelin may be more suitable for slightly older children with CPP. The gene discussed is GNRH1; the disease is central precocious puberty.